For example, activation of glucagon family receptors (GLP1R, GIPR, GCGR) shows therapeutic efficacy in treating type-2 diabetes and obesity [49]; however, these receptors are expressed in multiple tissues [50]. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.